TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24328847

Group type: EXPERIMENTAL
Intervention: A compound gel containing four amino acids and sodium hyaluronate (Aminogam(®), Errekappa, Italy)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No treatment involving a drug or gel (Control Group)
Number of subjects: 49
Study: 22374696

Group type: EXPERIMENTAL
Intervention: FLT3ITD mRNA level
Number of subjects: 648
Study: 19661804

Group type: EXPERIMENTAL
Intervention: Eritoran tetrasodium 105 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Eritoran tetrasodium 45 mg
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Eritoran tetrasodium 105 mg (high risk subgroup)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Eritoran tetrasodium 105 mg (low risk subgroup)
Number of subjects: 300
Study: 18382689

Group type: EXPERIMENTAL
Intervention: Mild anemia (hemoglobin concentration between 10.0 and 11.9 g/dL in women and 10.0 and 12.9 g/dL in men)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Non-anemic controls
Number of subjects: 170
Study: 16021544

Group type: EXPERIMENTAL
Intervention: MRI (T1wSE, STIR, postcontrast T1wSE-fatsat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MRI (T1wSE)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MRI (STIR)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MRI (postcontrast T1wSE-fatsat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MRI in patients with low histological infiltration (5-20% of bone marrow)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MRI in patients with high histological infiltration (>20% of bone marrow)
Number of subjects: 24
Study: 12771858

Group type: EXPERIMENTAL
Intervention: Short-term therapy with alprostadil (PGE(1))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term therapy
Number of subjects: 0
Study: 10608215

Group type: EXPERIMENTAL
Intervention: 20 mg cisapride p.o.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 9154421

Group type: EXPERIMENTAL
Intervention: Predischarge interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no predischarge interventions)
Number of subjects: 0
Study: 2210607

Group type: EXPERIMENTAL
Intervention: Penbutolol 40 mg/day orally
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7439241

Group type: EXPERIMENTAL
Intervention: Metoprolol 300 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg slow-release
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31662239

Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Placebo Aromatherapy
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Placebo Acupressure
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 85
Study: 31185312

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB) with 10 ml ropivacaine 0.5% at each level from T12 to L1
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Subarachnoid block (SAB) with 15 mg ropivacaine 0.5% at L3–L4 level
Number of subjects: 65

Group type: COMPARATOR
Intervention: Subarachnoid block (SAB)
Number of subjects: 65
Study: 28220309

Group type: EXPERIMENTAL
Intervention: Merocel packing (Group M)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Silicone splint (Group S)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Transseptal suturing (Group T)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (applied to Groups M and S)
Number of subjects: 90
Study: 26266436

Group type: EXPERIMENTAL
Intervention: Transepithelial corneal cross-linking
Number of subjects: 70

Group type: COMPARATOR
Intervention: Epithelium-off corneal cross-linking
Number of subjects: 70
Study: 24633272

Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Oral iron therapy
Number of subjects: 41
Study: 21217152

Group type: EXPERIMENTAL
Intervention: Photoelectric alarms with lithium batteries
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Ionisation alarms with carbon/zinc batteries
Number of subjects: 628

Group type: COMPARATOR
Intervention: Photoelectric alarms
Number of subjects: 628

Group type: COMPARATOR
Intervention: Alarms with lithium batteries
Number of subjects: 628

Group type: COMPARATOR
Intervention: Nuisance alarms
Number of subjects: 628
Study: 19748665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Darusentan 50 mg
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Darusentan 100 mg
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Darusentan 300 mg
Number of subjects: 379
Study: 17680844

Group type: EXPERIMENTAL
Intervention: Transperineal ultrasound
Number of subjects: 46

Group type: COMPARATOR
Intervention: Endoanal ultrasound
Number of subjects: 46
Study: 15172239

Group type: EXPERIMENTAL
Intervention: Water seal (group 1)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Suction (group 2)
Number of subjects: 145
Study: 15302013

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (1 g daily)
Number of subjects: 7000

Group type: EXPERIMENTAL
Intervention: Low-dose rosuvastatin (10 mg daily)
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Placebo for n-3 polyunsaturated fatty acids
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Placebo for rosuvastatin
Number of subjects: 7000
Study: 10340154

Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7742677

Group type: EXPERIMENTAL
Intervention: Intensive health care advice through six group sessions
Number of subjects: 681

Group type: COMPARATOR
Intervention: Usual health care advice
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Intensive health care advice
Number of subjects: 681
Study: 2248333

Group type: EXPERIMENTAL
Intervention: 1.5 mm posterior to the corneoscleral limbus
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3.0 mm posterior to the corneoscleral limbus
Number of subjects: 40
Study: 7372979

Group type: EXPERIMENTAL
Intervention: Bausch and Lomb Soflens contact lenses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hydrocurve HCII contact lenses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: AOSOFT‐TM/Aquaflex hydrophilic contact lenses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alcon Tresoft contact lenses
Number of subjects: 11
Study: 31630663

Group type: EXPERIMENTAL
Intervention: Zumba dancing
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 31513165

Group type: EXPERIMENTAL
Intervention: Magnetic laser radiation to the right subcostal area
Number of subjects: 50

Group type: COMPARATOR
Intervention: Basic treatment (oral intake of Jermuk mineral water, acupuncture, iodine‐bromine baths, massage, exercise therapy, therapeutic enemas)
Number of subjects: 50
Study: 29077960

Group type: EXPERIMENTAL
Intervention: Locomotor training (gait training on a treadmill with body‐weight support and overground training)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Strength and balance training
Number of subjects: 347
Study: 26627917

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation of HT7 with two PNS devices (1 Hz, 50 mA) during surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no electrical stimulation of HT7 during surgery)
Number of subjects: 120
Study: 24746829

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with increased dietary LCn-3PUFA intake
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 108
Study: 22776284

Group type: EXPERIMENTAL
Intervention: Patient-initiated review system (direct access group)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Regular clinician-initiated group
Number of subjects: 380
Study: 19463204

Group type: EXPERIMENTAL
Intervention: Combination inhaled corticosteroid and long‐acting beta(2)‐agonist (ICS/LABA) maintenance medication
Number of subjects: 509
Study: 17245343

Group type: EXPERIMENTAL
Intervention: TEGAFIRI (UFT 250 mg m(‐2) day days 1‐14, LV 90 mg day days 1‐14, irinotecan 240 mg m(‐2) day 1; q21)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: TEGAFOX (UFT 250 mg m(‐2) day days 1‐14, LV 90 mg day days 1‐14, oxaliplatin 120 mg m(‐2) day 1; q21)
Number of subjects: 143

Group type: COMPARATOR
Intervention: TEGAFIRI
Number of subjects: 143

Group type: COMPARATOR
Intervention: TEGAFOX
Number of subjects: 143
Study: 15738536

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg via 15-minute infusions every 4 weeks for 1 year)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 12118902

Group type: EXPERIMENTAL
Intervention: Limited anti-IL-2R monoclonal antibody (daclizumab) 2 mg/kg intraoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: No induction (control)
Number of subjects: 100
Study: 9613889

Group type: EXPERIMENTAL
Intervention: Ambulatory rotation
Number of subjects: 63
Study: 7662626

Group type: EXPERIMENTAL
Intervention: Krypton laser
Number of subjects: 12

Group type: COMPARATOR
Intervention: CW Nd:YAG laser
Number of subjects: 12
Study: 31842688

Group type: EXPERIMENTAL
Intervention: Surgical intervention for ICH evacuation
Number of subjects: 246
Study: 31294461

Group type: EXPERIMENTAL
Intervention: Autogenic training (AT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (closing eyes for 3 minutes)
Number of subjects: 26
Study: 28391531

Group type: EXPERIMENTAL
Intervention: Methylprednisolone for 2 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 29
Study: 27296660

Group type: EXPERIMENTAL
Intervention: Evaluation of Treatment (EOT) measure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment satisfaction factor
Number of subjects: 0
Study: 25061426

Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETT)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 297
Study: 22556050

Group type: EXPERIMENTAL
Intervention: Neuromuscular warm‐up programme (15 minutes, targeting core stability, balance, and proper knee alignment, twice a week for one season)
Number of subjects: 4564

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4564

Group type: EXPERIMENTAL
Intervention: Neuromuscular warm‐up programme
Number of subjects: 4564
Study: 19837764

Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan, 14.8 MBq/kg, as consolidation therapy after unlabeled rituximab 250 mg/m(2) on day -7
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: (90)Y-ibritumomab tiuxetan, 14.8 MBq/kg, as consolidation therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 70
Study: 16805722

Group type: EXPERIMENTAL
Intervention: Trospium chloride
Number of subjects: 0
Study: 14764803

Group type: EXPERIMENTAL
Intervention: rhGH (10 microg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: saline
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 14
Study: 11733394

Group type: EXPERIMENTAL
Intervention: rhuMAb CD18 (0.5 or 2.0 mg/kg)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study: 9223875

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl + A
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl + B
Number of subjects: 46

Group type: COMPARATOR
Intervention: Epidural bupivacaine (0.25%) + A
Number of subjects: 46

Group type: COMPARATOR
Intervention: Epidural bupivacaine + B
Number of subjects: 46
Study: 7968550

Group type: COMPARATOR
Intervention: Control condition with no interpolated task between tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imaginal processing interpolated tasks with pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal/linguistic processing interpolated tasks with words
Number of subjects: 0
Study: 2886716

Group type: EXPERIMENTAL
Intervention: Hydrazine sulphate (60 mg three times daily for 30 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29056562

Group type: EXPERIMENTAL
Intervention: Specialized palliative care (SPC) at home
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 322
Study: 27758050

Group type: EXPERIMENTAL
Intervention: Depleting e-crossing task
Number of subjects: 156

Group type: COMPARATOR
Intervention: Non-depleting task
Number of subjects: 156
Study: 25475591

Group type: EXPERIMENTAL
Intervention: Parent participation (PP) with 1 medical assistant
Number of subjects: 76

Group type: COMPARATOR
Intervention: Medical assistant-only group (2 medical assistants)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Parent participation (PP)
Number of subjects: 76
Study: 23523073

Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Home-based exercises
Number of subjects: 38
Study: 24482856

Group type: EXPERIMENTAL
Intervention: Directed writing focusing on sense-making
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Directed writing focusing on benefit-finding
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Traditional, non-directed emotional disclosure
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 68
Study: 19260845

Group type: EXPERIMENTAL
Intervention: Maca dry extract, 2400 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15668492

Group type: EXPERIMENTAL
Intervention: Total alcohol intake (quartiles)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Spirit consumption (quartiles)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Beer intake (quartiles)
Number of subjects: 195
Study: 12893197

Group type: EXPERIMENTAL
Intervention: poly(L-lactide/glycolide) (PLG) suture
Number of subjects: 203

Group type: COMPARATOR
Intervention: polypropolene (monofilament) suture
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Both PLG and monofilament sutures
Number of subjects: 203
Study: 10440793

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 0
Study: 8947448

Group type: EXPERIMENTAL
Intervention: Tidal volume of 6 ml/kg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tidal volume of 8 ml/kg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 ml/kg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tidal volume of 14 ml/kg
Number of subjects: 19
Study: 1721597

Group type: EXPERIMENTAL
Intervention: Antibiotics combined with immunomodulators
Number of subjects: 38

Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 38

Group type: COMPARATOR
Intervention: Antibiotics with gamma-globulin
Number of subjects: 38
Study: 7005778

Group type: EXPERIMENTAL
Intervention: Metronidazole combined with tobramycin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Clindamycin combined with tobramycin
Number of subjects: 47
Study: 31512717

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W or 150 mg Q2W (depending on baseline LDL-C levels)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 167
Study: 29952946

Group type: EXPERIMENTAL
Intervention: Percutaneous neuromuscular electrical stimulation (PNMES)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sham PNMES
Number of subjects: 124
Study: 26489744

Group type: EXPERIMENTAL
Intervention: Fibrin glue coverage (group B)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Oversewn SL with imbricating absorbable suture (Monocryl™; group C)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Oversewn SL with barbed running suture (V lock®; group D)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No SL reinforcement (group A)
Number of subjects: 600
Study: 25234040

Group type: EXPERIMENTAL
Intervention: Endometrial infusion of 500 IU of hCG diluted in ET media
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sham infusion of ET media (Control)
Number of subjects: 300
Study: 23104230

Group type: EXPERIMENTAL
Intervention: Sub-sunburn sunbed exposure (3 times a week)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Daily vitamin D supplementation (1000 IU)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 105
Study: 20951986

Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS) injection after endoscopic balloon dilation (EBD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo after endoscopic balloon dilation (EBD)
Number of subjects: 29
Study: 17659363

Group type: EXPERIMENTAL
Intervention: Minimal Intervention Strategy (MIS) group explored and discussed psychosocial prognostic factors.
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Minimal Intervention Strategy (MIS)
Number of subjects: 314
Study: 15573655

Group type: EXPERIMENTAL
Intervention: Alum in physiological saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Alum in distilled water
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 60
Study: 11574089

Group type: EXPERIMENTAL
Intervention: Artery skeletization (IMAS)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Dividing the IMA at its origin (Control)
Number of subjects: 163
Study: 9608349

Group type: EXPERIMENTAL
Intervention: Naloxone alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hydromorphone alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hydromorphone combined with naloxone
Number of subjects: 11
Study: 7933469

Group type: EXPERIMENTAL
Intervention: Epidural analgesia plus general anesthesia before surgery (Group 3)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epidural analgesia 20 min before the end of surgery under general anesthesia (Group 2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anesthesia alone (Group 1)
Number of subjects: 90
Study: 2450259

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine (5 mg/h during 85 min)
Number of subjects: 24
Study: 28726599

Group type: EXPERIMENTAL
Intervention: Staff training on evidence-based group interventions
Number of subjects: 1108
Study: 27149365

Group type: EXPERIMENTAL
Intervention: Hypertonic saline with hyaluronic acid (HS+HA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypertonic saline (HS)
Number of subjects: 0
Study: 24165436

Group type: EXPERIMENTAL
Intervention: Therapist-aided exposure treatment (n = 34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waiting list control condition (n = 34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Women without sexual problems (N = 70)
Number of subjects: 68
Study: 22554612

Group type: EXPERIMENTAL
Intervention: Medium-protein breakfast
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: High-protein breakfast
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control breakfast
Number of subjects: 136
Study: 20138810

Group type: EXPERIMENTAL
Intervention: Concurrent radiotherapy and letrozole (n=75)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sequential radiotherapy and letrozole (n=75)
Number of subjects: 150
Study: 18796081

Group type: EXPERIMENTAL
Intervention: Emails as a form of publicity
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Visiting GP practices as a form of publicity
Number of subjects: 332

Group type: COMPARATOR
Intervention: Questionnaire results
Number of subjects: 332
Study: 15834327

Group type: EXPERIMENTAL
Intervention: Preoperative epidural anesthesia with morphine (Group E)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inhalation general anesthesia with sevoflurane and intermittent intravenous administration of fentanyl (Group F)
Number of subjects: 40
Study: 12022306

Group type: EXPERIMENTAL
Intervention: NIDCAP care
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional care (Control)
Number of subjects: 22
Study: 10561813

Group type: EXPERIMENTAL
Intervention: Nifedipine OROS 30 mg once daily (titrated to 60 mg if DBP > 90 mmHg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg once daily (titrated to 10 mg if DBP > 90 mmHg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nifedipine OROS
Number of subjects: 23

Group type: COMPARATOR
Intervention: Felodipine ER
Number of subjects: 23
Study: 8722432

Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide 10/12.5 mg
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Fosinopril/Hydrochlorothiazide 20/12.5 mg
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 1916322

Group type: EXPERIMENTAL
Intervention: polyvinyl alcohol 1.4% + chlorobutanol 0.5%
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: polyvinyl pyrrolidone 2% without preservative
Number of subjects: 68

Group type: COMPARATOR
Intervention: polyvinyl pyrrolidone 2% + benzalkonium chloride 0.005%
Number of subjects: 68
Study: 6891699

Group type: EXPERIMENTAL
Intervention: Estradiol-17 beta (200 micrograms, administered every other day for 10 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg, administered every other day for 10 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dihydrotestosterone (200 mg, administered every other day for 10 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sesame oil vehicle (Control)
Number of subjects: 12
Study: 31089895

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2% lignocaine with 1:80,000 epinephrine
Number of subjects: 60